Update date
31 Mar 2019
Shareable Research Card
GRCE - Grace Therapeutics, Inc. Current Assets
This metric view shows GRCE - Grace Therapeutics, Inc. current assets history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2019
- Latest reported value
- CA$37,331,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Mar 2019
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q1 2019.
- Latest reported value on this page: CA$37,331,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Current Assets
Latest reported current assets: CA$37,331,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q1 2019
SEC-backed company facts were refreshed from filings filed on 18 Jun 2026.
Benchmark Context
How Current Assets compares with peers
Grace Therapeutics, Inc. sits in the upper half of the current current assets sample.
Compared with
Compared with 7 companies reporting current assets in CAD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 2x the current sample midpoint. Current Assets is up about 293% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Aug 2018 to 31 Jan 2026.
- Nearby companies in this sample: Cronos Group Inc. and Profound Medical Corp..
- Current sample position: rank #2 of 7 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Grace Therapeutics, Inc.: Current Assets
Latest period: Q1 2019. Period end: 31 Mar 2019. Units: CAD. Frequency: quarterly.
Current Assets is reported in company XBRL facts filed with the SEC.
Metric snapshot
- Latest value
- CA$37,331,000
- Coverage range
- 31 Mar 2017 - 31 Mar 2019
- Fact rows
- 3
What this metric tells you
- Shows reported current assets over 31 Mar 2017 - 31 Mar 2019.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 3 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Current Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Grace Therapeutics, Inc. appears at rank #2 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | Cronos Group Inc. (cron) | CA$65,064,000 | Instant - 31 Dec 2018 | Open Cronos Group Inc. Current Assets |
| 2 | Grace Therapeutics, Inc. (grce) | CA$37,331,000 | Instant - 31 Mar 2019 | Open Grace Therapeutics, Inc. Current Assets |
| 3 | Profound Medical Corp. (prof) | CA$29,621,000 | Instant - 31 Dec 2019 | Open Profound Medical Corp. Current Assets |
| 4 | MindWalk Holdings Corp. (hyft) | CA$18,815,000 | Instant - 31 Jan 2026 | Open MindWalk Holdings Corp. Current Assets |
| 5 | Foremost Clean Energy Ltd. (fmst) | CA$5,360,540 | Instant - 31 Mar 2025 | Open Foremost Clean Energy Ltd. Current Assets |
| 6 | PSYENCE BIOMEDICAL LTD. (pbm) | CA$1,590,255 | Instant - 31 Mar 2023 | Open PSYENCE BIOMEDICAL LTD. Current Assets |
Metric Details
- Metric
- Current Assets (CurrentAssets)
- Frequency coverage
-
quarterly
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- ifrs-full
- Units tracked
- CAD
- History range
-
31 Mar 2017 - 31 Mar 2019
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
3
Source: SEC company facts API
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Current Assets, Quarterly (CAD)
Current Assets, YoY Quarterly Change (%)
Grace Therapeutics, Inc. Quarterly Current Assets (CAD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q1 2019 | CA$37,331,000 | +CA$27,839,000 | +293% | 31 Mar 2019 | 20-F | 26 Jun 2019 | 2019 | FY |
| Q1 2018 | CA$9,492,000 | -CA$789,000 | -7.7% | 31 Mar 2018 | 20-F | 26 Jun 2019 | 2019 | FY |
| Q1 2017 | CA$10,281,000 | 31 Mar 2017 | 20-F | 29 Jun 2018 | 2018 | FY |
* marks a reported value that did not pass the local value check.